Hospital
The East Alabama Health Care Authority
The East Alabama Health Care Authority was paid $6.19M by Medicaid between Jan 2018 and Dec 2024, across 166 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
33Billing provider infoTHE EAST ALABAMA HEALTH CARE AUTHORITY
OPELIKA, AL 36801
OPELIKA, AL 36801
33aNPI1154386431assigned 04/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.19M
24GClaims261,289
24DCodes billed166
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#9 of 77
Median peer was paid$1.13M
This provider vs. median5.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PRICE, SAMUEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,075 | $867K | |
| 2019 | 49,842 | $881K | |
| 2020 | 28,342 | $522K | |
| 2021 | 29,846 | $629K | |
| 2022 | 34,236 | $828K | |
| 2023 | 42,943 | $1.39M | |
| 2024incomplete | 29,005 | $1.07M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 26,144 | 25,152 | $1.76M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 27,620 | 26,655 | $1.09M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 11% | 15,732 | 14,023 | $676K |
| 80053 | Comprehensive metabolic panel | 4.8% | 28,052 | 25,886 | $294K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.8% | 27,342 | 25,161 | $234K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 2.9% | 1,017 | 953 | $180K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.1% | 480 | 468 | $127K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.5% | 1,685 | 1,520 | $94K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.5% | 3,734 | 3,452 | $91K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.4% | 328 | 318 | $90K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.4% | 1,201 | 673 | $85K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.4% | 3,877 | 3,544 | $84K |
154 more codes
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.2% | 3,512 | $77K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 5,370 | $64K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,854 | $55K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,419 | $55K |
| 86762 | <1% | 2,765 | $53K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,136 | $51K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,371 | $48K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,772 | $46K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,498 | $45K |
| 87340 | <1% | 3,377 | $44K | |
| G0378 | Hospital observation service, per hour | <1% | 1,514 | $42K |
| 80061 | Lipid panel | <1% | 2,290 | $39K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 717 | $35K |
| 84702 | <1% | 2,937 | $35K | |
| 86850 | <1% | 5,433 | $34K | |
| 86592 | <1% | 6,177 | $33K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,151 | $33K |
| 85027 | <1% | 7,128 | $32K | |
| 87536 | <1% | 1,203 | $32K | |
| 87070 | <1% | 2,328 | $26K | |
| 81003 | <1% | 8,966 | $24K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 134 | $24K |
| 88307 | <1% | 143 | $21K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 108 | $20K |
| 86360 | <1% | 478 | $18K | |
| 86803 | <1% | 924 | $17K | |
| 87428 | <1% | 385 | $17K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 524 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 973 | $15K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,120 | $15K |
| 82950 | <1% | 2,220 | $15K | |
| 76830 | Ultrasound, transvaginal | <1% | 480 | $14K |
| 82105 | <1% | 658 | $14K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 750 | $13K |
| 83021 | <1% | 885 | $13K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,154 | $13K |
| 84146 | <1% | 417 | $11K | |
| 82677 | <1% | 363 | $11K | |
| 83735 | <1% | 1,353 | $10K | |
| 83002 | <1% | 462 | $10K | |
| 83001 | <1% | 456 | $10K | |
| 84439 | <1% | 1,012 | $10K | |
| 83020 | <1% | 531 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,061 | $9K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 117 | $9K |
| 86900 | <1% | 3,247 | $9K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,026 | $9K |
| 86901 | <1% | 3,234 | $9K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 377 | $7K |
| 86336 | <1% | 363 | $7K | |
| 59025 | Fetal non-stress test | <1% | 1,261 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 156 | $6K |
| 88182 | <1% | 838 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 160 | $5K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 38 | $5K |
| 87625 | <1% | 196 | $5K | |
| 85652 | <1% | 1,408 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 242 | $4K |
| 93976 | <1% | 47 | $4K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 32 | $4K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 18 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 105 | $4K |
| 77336 | <1% | 192 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 58 | $3K |
| 43235 | <1% | 12 | $3K | |
| 36902 | <1% | 55 | $3K | |
| 87807 | <1% | 207 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 174 | $2K |
| 83655 | <1% | 135 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 349 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 38 | $2K |
| 85045 | <1% | 286 | $2K | |
| 93458 | <1% | 12 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 32 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 104 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 26 | $1K |
| 81025 | <1% | 370 | $1K | |
| 84484 | <1% | 190 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 559 | $926.81 |
| 85014 | <1% | 2,266 | $901.22 | |
| 85018 | <1% | 2,265 | $897.75 | |
| 84466 | <1% | 39 | $894.24 | |
| 82570 | <1% | 122 | $869.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,011 | $861.05 |
| 86140 | <1% | 580 | $586.95 | |
| 80069 | <1% | 97 | $586.74 | |
| 82607 | <1% | 26 | $572.01 | |
| 96367 | <1% | 19 | $567.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 939 | $541.12 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 34 | $533.50 |
| 82728 | <1% | 39 | $532.80 | |
| 95816 | <1% | 12 | $525.84 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,165 | $505.55 |
| 85041 | <1% | 1,005 | $505.38 | |
| 84156 | <1% | 106 | $497.87 | |
| 80076 | <1% | 63 | $484.88 | |
| 83615 | <1% | 61 | $440.55 | |
| 94729 | <1% | 17 | $435.96 | |
| 87088 | <1% | 54 | $429.12 | |
| 82803 | <1% | 16 | $399.42 | |
| 94726 | <1% | 17 | $398.02 | |
| 83540 | <1% | 39 | $367.20 | |
| 88300 | <1% | 184 | $355.40 | |
| 80164 | <1% | 15 | $352.94 | |
| 82140 | <1% | 14 | $317.52 | |
| 86787 | <1% | 13 | $293.52 | |
| 84460 | <1% | 33 | $281.07 | |
| 82565 | <1% | 243 | $251.86 | |
| 84450 | <1% | 33 | $248.36 | |
| 76801 | <1% | 16 | $234.53 | |
| 87186 | <1% | 39 | $222.42 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 381 | $191.05 |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 32 | $182.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,017 | $145.96 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 718 | $143.84 |
| 87081 | <1% | 12 | $133.50 | |
| 82248 | <1% | 25 | $118.45 | |
| 80051 | <1% | 114 | $103.51 | |
| 82947 | <1% | 666 | $93.00 | |
| 84520 | <1% | 201 | $81.20 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 29 | $73.80 |
| 86706 | <1% | 14 | $72.75 | |
| 82375 | <1% | 15 | $68.64 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 480 | $60.22 |
| 83690 | <1% | 13 | $56.56 | |
| 81001 | <1% | 12 | $49.12 | |
| J2704 | Injection, propofol, 10 mg | <1% | 660 | $42.40 |
| 84132 | <1% | 454 | $40.32 | |
| 84295 | <1% | 453 | $40.32 | |
| 83050 | <1% | 15 | $38.22 | |
| 85049 | <1% | 17 | $26.94 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 37 | $22.64 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 881 | $16.62 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 304 | $14.12 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 33 | $12.82 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,471 | $12.52 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,195 | $8.20 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 12 | $6.22 |
| 36415 | Collection of venous blood by venipuncture | 0% | 355 | $0.00 |
| 86361 | 0% | 637 | $0.00 | |
| 29581 | 0% | 170 | $0.00 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 90 | $0.00 |
| 82962 | 0% | 231 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 86 | $0.00 |
| C1769 | Guide wire | 0% | 123 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 39 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 13 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 15 | $0.00 |
| J3490 | Unclassified drugs | 0% | 51 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 26 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 124 | $0.00 |
| 99152 | 0% | 77 | $0.00 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 12 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRICE, SAMUEL (CFO)
| Provider | Location | Paid |
|---|---|---|
| B. J. Price, INC | Doniphan, MO | $12.49M |
| East Alabama EMS, LLC | Opelika, AL | $2.58M |
| Eamc Er Physicians | Opelika, AL | $2.55M |
| Eamc Physicians Group | Opelika, AL | $1.07M |
| East Alabama Physicians, LLC | Opelika, AL | $771K |
| Primary Medicine Associates, LLC | Auburn, AL | $650K |
| The East Alabama Health Care Authority | Valley, AL | $582K |
| Valley Area Primary Care, LLC | Valley, AL | $502K |
| East Alabama Maternal Fetal Medicine | Auburn, AL | $341K |
| East Alabama Heart and Vascular, LLC | Opelika, AL | $297K |
| Rehabworks LLC | Opelika, AL | $199K |
| East Alabama Orthopaedics and Sports Medicine, LLC | Opelika, AL | $158K |
| Neurology Center of East Alabama, LLC | Opelika, AL | $94K |
| East Alabama Health Services LLC | Opelika, AL | $54K |
| Urology Associates of East Alabama LLC | Opelika, AL | $31K |
| Valley Internal Medical Associates LLC | Valley, AL | $15K |
| Endocrinology and Metabolism of East Alabama LLC | Opelika, AL | $2K |
| Eamc-Lanier Ambulatory Surgery Center, LLC | Valley, AL | $2K |
| Eamc Eye Clinic, LLC | Opelika, AL | $0.00 |
| The East Alabama Health Care Authority | Opelika, AL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.